ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,170,000 shares, a growth of 598.6% from the May 15th total of 310,600 shares. Currently, 10.4% of the shares of the stock are […]
ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)." In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Risk and Volatility ReShape Lifesciences has a beta […]
ReShape Lifesciences Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.